Aurigene Pharmaceutical Services Ltd will establish its state-of-the-art biomanufacturing facility at an investment of USD 40 million here, which will generate employment to more than 250 people. Aurigene Pharmaceutical Services is a city-based leading contract research, development, and manufacturing organization (CRO/CDMO) and a long-term partner providing end-to-end solutions thereby accelerating innovation.